Clinical Trials

TECLens begins first-in-human trial for qCXL vision correction technology

TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

Kandu trial highlights positive outcomes with IpsiHand BCI system

Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy. The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...

CorTec announces successful second human implantation of its BCI system

CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...

Atraverse reports positive data for Hotwire transseptal access system

Atraverse Medical announced new clinical and preclinical data supporting its Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It...

Artivion’s aortic stents boost post-surgical outcomes in interventional studies

Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended benefits to patients. This includes...

Biotronik completes first human implants of LivIQ leadless pacemaker

Biotronik announced the successful first-in-human implantations of its LivIQ leadless pacemaker system. The implants came in Australia as part of the company’s BIO|CONCEPT.LivIQ study, a...

Robocath launches first-in-human study of next-gen robot for coronary artery disease

Robocath announced that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease. The Rouen, France-based company said its second-generation...

ReGelTec shows Percutaneous Hydrogel Implant improves chronic low back pain

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced the...
1234...59Page 3 of 59

Latest articles